Dr Reddy's Laboratories has recalled 13,560 bottles of the high blood pressure drug metoprolol succinate in the United States after it failed a dissolution test. In the previous month, Wockhardt had also recalled 109,744 bottles of the same drug citing the same reason.
FDA has classified the Dr Reddy's recall as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.
Back in March too, the company recalled about 58,656 bottles of the heartburn drug lansoprazole in the United States in March due to a microbial contamination.Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.